Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic immune profiling of Omicron-infected subjects inoculated with different doses of inactivated virus vaccine
Shanhe Yu, Yingni Lin, Yong Li, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4615-4631.e16
Open Access | Times Cited: 13

Showing 13 citing articles:

SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 44
Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial
Jie Xu, Baiyan Wang, Shanhe Yu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 23
Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs
Airu Zhu, Chen Zhao, Qihong Yan, et al.
Nature Immunology (2025)
Open Access | Times Cited: 2
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Dennis Lapuente, Thomas Winkler, Matthias Tenbusch
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 144-158
Open Access | Times Cited: 29
Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppression
Kimia Kamelian, Benjamín L. Sievers, Michael Chen‐Xu, et al.
Science Advances (2025) Vol. 11, Iss. 7
Open Access
Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections
Zhen Zhuang, Jianfen Zhuo, Yaochang Yuan, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 478-478
Open Access | Times Cited: 3
Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2
Jingbo Huang, Weiqi Wang, Hailun Li, et al.
Antiviral Research (2024) Vol. 227, pp. 105905-105905
Closed Access | Times Cited: 3
T cell hybrid immunity against SARS-CoV-2 in children: a longitudinal study
Martin Qui, Smrithi Hariharaputran, Shou Kit Hang, et al.
EBioMedicine (2024) Vol. 105, pp. 105203-105203
Open Access | Times Cited: 2
Booster vaccination: host preparation against Omicron challenge by innate immunity training
Lan Bai, Fangfang Zhou, Long Zhang
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 1
Single-cell multiomics analysis reveals SARS-CoV-2 inactivated vaccine-induced trained immunity modulated by epigenetic remodeling
Zijie Zhang, Rong Wang, Huajie Hu, et al.
Research Square (Research Square) (2024)
Open Access
The roles of innate and adaptive immunity in inactivated viral vaccination‐mediated protection against COVID‐19
Shanhe Yu, Shi-Jun Chen, Jiang Zhu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 1
Open Access
Systemic and dynamic immune landscape of Omicron-infected subjects treated with Lianhua Qingwen capsules
Shijun Chen, Fuxiang Wang, Yuanlong Lin, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 5074-5078
Open Access
Inactivated vaccine dosage and serum IgG levels correlate with persistent COVID-19 infections in hematologic malignancy patients during the Omicron Surge in China
Ye Li, Ye Yang, Xuewu Zhang, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Page 1

Scroll to top